Mylinh Dang

443 total citations
8 papers, 173 citations indexed

About

Mylinh Dang is a scholar working on Genetics, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Mylinh Dang has authored 8 papers receiving a total of 173 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 6 papers in Surgery and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Mylinh Dang's work include Diabetes and associated disorders (8 papers), Pancreatic function and diabetes (6 papers) and Diabetes Management and Research (5 papers). Mylinh Dang is often cited by papers focused on Diabetes and associated disorders (8 papers), Pancreatic function and diabetes (6 papers) and Diabetes Management and Research (5 papers). Mylinh Dang collaborates with scholars based in United States. Mylinh Dang's co-authors include Janet M. Wenzlau, Kathryn Haskins, Thomas Delong, Rocky L. Baker, Liping Yu, Jennifer Rockell, Peter A. Gottlieb, John C. Hutton, R. Wagner and Howard W. Davidson and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Diabetes.

In The Last Decade

Mylinh Dang

6 papers receiving 172 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mylinh Dang United States 6 139 104 81 58 20 8 173
Lisa Fitzgerald-Miller United States 7 203 1.5× 146 1.4× 126 1.6× 120 2.1× 24 1.2× 7 269
Kyla Chandler United Kingdom 5 101 0.7× 86 0.8× 71 0.9× 27 0.5× 35 1.8× 5 146
Claudia Peplow Germany 2 116 0.8× 97 0.9× 90 1.1× 32 0.6× 8 0.4× 2 145
Jamie L. Felton United States 7 116 0.8× 94 0.9× 83 1.0× 75 1.3× 11 0.6× 17 172
Mohamed M. Jahromi United States 8 223 1.6× 160 1.5× 156 1.9× 80 1.4× 30 1.5× 10 303
Ursule Van de Velde Belgium 9 334 2.4× 285 2.7× 274 3.4× 92 1.6× 18 0.9× 16 398
Alexandra Fouts United States 8 240 1.7× 208 2.0× 163 2.0× 38 0.7× 58 2.9× 9 282
Joanna Kramer United States 5 102 0.7× 64 0.6× 54 0.7× 56 1.0× 51 2.5× 5 166
Henna Kallionpää Finland 6 164 1.2× 103 1.0× 88 1.1× 86 1.5× 53 2.6× 8 250
Ellen Adlem United Kingdom 3 72 0.5× 51 0.5× 21 0.3× 20 0.3× 55 2.8× 3 121

Countries citing papers authored by Mylinh Dang

Since Specialization
Citations

This map shows the geographic impact of Mylinh Dang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mylinh Dang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mylinh Dang more than expected).

Fields of papers citing papers by Mylinh Dang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mylinh Dang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mylinh Dang. The network helps show where Mylinh Dang may publish in the future.

Co-authorship network of co-authors of Mylinh Dang

This figure shows the co-authorship network connecting the top 25 collaborators of Mylinh Dang. A scholar is included among the top collaborators of Mylinh Dang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mylinh Dang. Mylinh Dang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Hohenstein, Anita C., Mylinh Dang, Kathleen Waugh, et al.. (2025). Novel T-Cell Reactivities to Hybrid Insulin Peptides in Islet Autoantibody–Positive At-Risk Individuals. Diabetes. 74(6). 933–942.
2.
Nicholson, K. M., Mylinh Dang, Janet M. Wenzlau, et al.. (2025). Strategic Reduction of Hybrid Insulin Peptide Formation Significantly Delays Diabetes Onset in NOD Mice. Diabetes. 75(1). 115–123.
3.
Dang, Mylinh, Cole R. Michel, Roger Powell, et al.. (2023). Hybrid insulin peptide isomers spontaneously form in pancreatic beta-cells from an aspartic anhydride intermediate. Journal of Biological Chemistry. 299(11). 105264–105264. 5 indexed citations
4.
Wenzlau, Janet M., Gene Barbour, Mylinh Dang, et al.. (2022). Insulin B-chain hybrid peptides are agonists for T cells reactive to insulin B:9-23 in autoimmune diabetes. Frontiers in Immunology. 13. 926650–926650. 11 indexed citations
5.
Wiles, Timothy A., Janet M. Wenzlau, Roger Powell, et al.. (2022). Cathepsin D Drives the Formation of Hybrid Insulin Peptides Relevant to the Pathogenesis of Type 1 Diabetes. Diabetes. 71(12). 2793–2803. 33 indexed citations
6.
Wiles, Timothy A., Anita C. Hohenstein, Laurie G. Landry, et al.. (2021). Characterization of Human CD4 T Cells Specific for a C-Peptide/C-Peptide Hybrid Insulin Peptide. Frontiers in Immunology. 12. 23 indexed citations
7.
Delong, Thomas, Mylinh Dang, I‐Ting Chow, et al.. (2020). Hybrid Insulin Peptides Are Recognized by Human T Cells in the Context of DRB1*04:01. Diabetes. 69(7). 1492–1502. 41 indexed citations
8.
Dang, Mylinh, Jennifer Rockell, R. Wagner, et al.. (2011). Human Type 1 Diabetes Is Associated with T Cell Autoimmunity to Zinc Transporter 8. The Journal of Immunology. 186(10). 6056–6063. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026